Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Other hematologic neoplasm 1Lymphoid 1Genitourinary 1Gastrointestinal 1CNS 1Breast 1

Conditions

Glioblastoma 9Neoplasms 3Medulloblastoma 2Brain Neoplasms 2Sarcoma 1Recurrence 1Pancreatic Neoplasms 1Neoplasm Recurrence, Local 1Neoplasm Metastasis 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Leukemia-Lymphoma, Adult T-Cell 1Kidney Neoplasms 1Hereditary Sensory and Autonomic Neuropathies 1Gliosarcoma 1Glioma 1Colorectal Neoplasms 1Central Nervous System Neoplasms 1Breast Neoplasms 1Bone Neoplasms 1

Interventions

Specimen Handling 54Carboplatin 51pembrolizumab 50Magnetic Resonance Spectroscopy 46Pemetrexed 41Cisplatin 36durvalumab 26Paclitaxel 25Nivolumab 23osimertinib 22Radiosurgery 20Gemcitabine 20Radiotherapy 17Docetaxel 17Immunoglobulin G 15Biopsy 15atezolizumab 14Disulfides 14130-nm albumin-bound paclitaxel 13Taxes 12Radiation 11Etoposide 11Educational Status 11Blood Specimen Collection 11Drug Therapy 10X-Rays 9Platinum 9Early Intervention, Educational 9Practice Guidelines as Topic 8Methods 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lung Neoplasms × Lomustine × 90 days × Clear all
NCT03678883 2026-04-03

9-ING-41 in Patients With Advanced Cancers

Actuate Therapeutics Inc.

Phase 2 Active not recruiting
350 enrolled
BreastCNSGastrointestinalGenitourinaryLymphoidOther hematologic neoplasmSarcomaThoracic

Bone Neoplasms, Breast Neoplasms, Glioma, Kidney Neoplasms, Lung Neoplasms, Lymphoma, Non-Hodgkin, Neoplasm Metastasis, Neoplasms, Hereditary Sensory and Autonomic Neuropathies, Pancreatic Neoplasms, Sarcoma, Colorectal Neoplasms, Leukemia-Lymphoma, Adult T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡